Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 267647
                    [Title] => Evidence mounts for gut worm therapy
                    [Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy. 


In addition, in an open-label study of 29 patients with refractory Crohn’s disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission. 

                    [DatePublished] => 2005-01-02 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

OVA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 267647
                    [Title] => Evidence mounts for gut worm therapy
                    [Summary] => Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind, randomized, placebo-controlled study that included 54 patients with ulcerative colitis (UC), approximately 50 percent of the patients responded to Trichurisuis ova therapy. 


In addition, in an open-label study of 29 patients with refractory Crohn’s disease (CD), 79.3 percent of the subjects responded to treatment, and 72.4 percent achieved clinical remission. 

                    [DatePublished] => 2005-01-02 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Evidence mounts for gut worm therapy

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | January 2, 2005 - 12:00am

Two sets of findings presented at the 2004 Digestive Disease Week meeting lend strength to the belief that helminthic therapy may be a highly effective treatment for inflammatory bowel disease (IBD) in a double-blind,...

Opinion